HT JOINS EU CONSORTIUM LIFETIME
Human Technopole is now an Associate Partner of LifeTime, the pan-European research initiative that aims to revolutionise healthcare by tracking and understanding human diseases at single cell resolution to transform patients’ care and the sustainability of healthcare systems.
Joining the LifeTime community is an important opportunity for Human Technopole to build a strategic network of relevant European partners that share our ambition and goals.
Human Technopole’s mission is fully aligned with LifeTime’s overarching aim to tackle complex human diseases. Specifically, the three defining pillars of LifeTime (single-cell multiomics, organoids and machine learning-based deconvolution) are represented in HT by the close integration of Centres and Core Facilities featuring leading expertise in these fields.
Together with the University of Milan, the European Institute of Oncology (IEO) and the Sacco Hospital, Human Technopole is already part of the Italian branch of the initiative Lifetime for COVID19, which for the upcoming two years will be led by the Head of our Research Centre for Neurogenomics, Prof. Giuseppe Testa.
The LifeTime consortium gathers over 120 leading scientists from over 90 European research institutes. The University of Milan is the Italian partner of the consortium and other Italian associate partners include the European Institute of Oncology, Fondazione Istituto FIRC di Oncologia Molecolare, the Institute for Biomedical Technologies and the Institute of Photonics and Nanotechnologies of the Italian National Research Council as well as many prominent Italian universities.
Share:
You could also like:
Derailing molecular cargo trains in cilia makes them turn around
Researchers at the Human Technopole and Max Planck Institute of Molecular Cell Biology and Genetics show how molecular cargo trains change direction in cellular micro-antennas. Cilia are antenna-like structures that protrude outwards from the surface of eukaryotic cells. Misassembled cilia in humans can cause numerous diseases from infertility to lung malfunction. The assembly and maintenance […]
Cilia in 3D: Miniature train station discovered
Cilia are hair-like organelles that extend from most eukaryotic cells and perform many functions, including motility and signaling. Together with collaborators at the University of Geneva (Hamel-Guichard lab) and Biozentrum, University of Basel (Engel Lab), Dr. Gaia Pigino’s Group at the Human Technopole in Milan has now revealed that cilia have a specialised transport hub […]
New tools for the analysis of CRISPR-Cas9 screens
Supervised classification methods can be used for the analysis of genetic screens obtained through the CRISPR-Cas9 genome editing technology. Nevertheless, these methods require large sets of reference genes to be included among those targeted with CRISPR. Alessandro Vinceti, of the Iorio Group, presents a novel computational method to identify reference gene sets of minimal size […]
A new approach to investigate the impact of retrotransposon recombination on human genome
Recombination of retrotransposons is known to affect genome stability and evolution, yet the significance of this process and its impact on the genome of human somatic cells are poorly understood. Giovanni Pascarella and Piero Carninci set up a new framework enabling comprehensive studies of retrotransposon recombination-driven genomic diversity in healthy and diseased tissues. The DNA […]
Francesca Ieva on Lombardy Region Taskforce
Our Associate Head of the Health Data Science Centre has been appointed to a new task force created by Lombardy Region which aims to reduce waiting lists and verify the proper management in the provision of health services to citizens. The task force includes members from Lombardy Region Welfare General Management, ATS, ASST, Lombardy Health […]